Atul Arvind Vasani, Chairman and Managing Director of the Company says that: “Adapting quickly to the ever-evolving demands, the Company has emerged as one of the fastest-growing organization in the Pharmaceutical Industry for the supply of Medical Products to Domestic & International Market, and in this Covid-19 Pandemic, we are trying to reach maximum people with quality medical products at affordable price."
Vasani added, "The Company is expecting a tremendous growth and a better quarterly performance along with many more opportunities from the Domestic as well as International Market in near future.”
According to the regulatory filing, the Personal Protective Equipment (PPE) refers to the protective clothing, helmets, gloves, face shields, goggles, facemasks and/or respirators or other equipment designed to protect the wearer from injury or the spread of infection or illness. The Disposable Coverall suits are one-piece fitting for ease of movement, with sleeves, full leggings and often a hood to cover the head. The gloves help to protect when directly handling potentially infectious materials or contaminated surfaces. Facemasks help protect the nose and mouth from splattered of body fluids and other airborne infections before inhalation. A face shield provides splatter protection to facial skin, eyes, nose, and mouth. Shoe and headcovers provide a barrier against possible exposure within a contaminated environment.
Also, the range of different Covid-19 medical products such as hand sanitiser, 3 ply mask, N95 Masks, KN95 Masks, IR Thermometer, Oximeter, Face Shield, Sanitizer Stand, Sanitizer Dispenser, goggles, gloves etc. The multivitamin sprays such as `Vipramultivita spray, Vipravita D3 spray, Viprafolic A spray, Vipravta spray. The Immunity Booster such as Vipravita C supplements in different variants viz. – Vitamin C chewable tablets, Vitamin C effervescent tablets and Vitamin C with Zinc combo to fight against COVID -19 pandemic.
On NSE, Vaishali Pharma settled at the upper price band of Rs52.55 per piece up 5%.